1. Girolami, A., Molaro, G., and De Marco, L., Factor X survival and therapeutic factor X levels in the abnormal factor X (factor X Friuli) coagulation disorder, Acta Haematol., 1974, vol. 52, no. 4, pp. 223–231.
2. Chatterjee, T., Philip, J., Nair, V., Mallhi, R.S., Sharma, H., Ganguly, P., and Biswas, A.K., Inherited factor X (Stuart-Prower factor) deficiency and its management, Med. J. Armed Forces India, 2015, vol. 71, suppl. 1, pp. S184–S186.
3. Tsevrenis, H., Mandalaki, T., Symvoulidis, A., and Philips, H., Fluctuations and relations of the Quick time and the heparin tolerance test and the X factor during anticoagulant treatment with coumarins, Arch. Inst. Pasteur Hell., 1961, vol. 7, pp. 49–58.
4. Sajevic, T., Leonardi, A., and Križaj, I., Haemostatically active proteins in snake venoms, Toxicon, 2011, vol. 57, no. 5, pp. 627–645.
5. Bobrovskaya, A.A., Osmolovskii, A.A., Zvonareva, E.S., Kreier, V.G., and Kurakov, A.V., Proteinases of micromycetes with the activities of human hemostasis enzymes, Usp. Med. Mikol., 2015, vol. 14, no. 14, pp. 414–416.